ACC 26 Announces Featured Clinical Research Sessions
SOURCE: American College of Cardiology
PUBLISHED:

The American College of Cardiology's 76th Annual Scientific Session (ACC.26) has announced its featured clinical research program, showcasing innovative trials and registries across coronary vasomotor disorders, digital health interventions, lipid management, heart failure, and advanced cardiac imaging.

These sessions will present cutting-edge research by leading investigators, with presentations scheduled across Saturday 28 March through Monday 30 March 2026.

 

Featured Clinical Research Session I

Saturday 28 March 2026, 12:00–12:55 CST

  • A Prospective Multicenter Registry to Define Coronary Vasomotor Disorders in Ischemia with Nonobstructive Coronary Arteries: Primary Results of DISCOVER INOCA – Presented by Dr Samit Shah
  • Impact of Ivabradine on Orthostatic Intolerance, Quality of Life and Heart Rate in Post-COVID Postural Orthostatic Tachycardia Syndrome: Results from the RECOVER-Autonomic Trial – Presented by Dr Pam Taub
  • Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Sex Differences in Underlying Causes of Myocardial Infarction with No Obstructive Coronary Arteries – Presented by Dr Harmony Reynolds

  • A Sham Controlled Randomised Trial Evaluating the Safety, Acceptability and Efficacy of Autonomic Neuromodulation Using Trans-Cutaneous Vagal Sensory Stimulation in Uncontrolled Hypertensive Patients – Presented by Dr Ajay Gupta

     

Featured Clinical Research Session II

Saturday 28 March 2026, 13:30–14:25 CST

  • Effects of Tirzepatide Compared with Dulaglutide on Expanded Cardiorenal Outcomes – Presented by Dr Steven Nissen
  • Prevalence and Clinical Impact of Hypercortisolism in Individuals with Resistant Hypertension: Primary Results from the MOMENTUM Study – Presented by Dr Deepak Bhatt
  • Reliability of CAC=0 to Exclude Coronary Plaque in Diverse Global Cohorts: A Global Probability Study of Coronary Artery Disease (GPS-CAD) Analysis – Presented by Dr Lohendran Baskaran

  • Community-to-Clinic Linkage Implementation Program to Prevent Hypertension in Barbershops – Presented by Dr Joseph Ravenell

     

Featured Clinical Research Session III

Sunday 29 March 2026, 12:15–13:10 CST

  • 10-Year Follow-Up of Clopidogrel vs Aspirin Monotherapy in Stable Coronary Artery Disease After Percutaneous Coronary Intervention with Drug-Eluting Stent – Presented by Dr Hyo-Soo Kim
  • Coronary CT Derived Fractional Flow Reserve-Guided Management of Patients with Stable CAD: 3-Year Outcomes from a Multicentre, Pragmatic, Open-Label, Randomised Controlled Trial in China – Presented by Dr Chunxiang Tang
  • Role of Screening with Coronary Computed Tomography Angiography in Lipid Management in an Asymptomatic Chinese Population: A Community-Based, Parallel-Group, Open-Label, Randomized Clinical Trial (RESPECT2) – Presented by Dr Xiang Guo

  • Targeted Assessment in High-Risk Patients with Diabetes to Identify Undiagnosed Heart Failure – Presented by Dr Daniel Taylor-Sweet

     

Featured Clinical Research Session IV

Sunday 29 March 2026, 13:45–14:40 CST

  • MUTTON-HF (Medically Utilized Tailored Traditional Foods to Optimize Nutrition in Heart Failure): A Randomized Controlled Trial of an Indigenous Food Is Medicine Intervention – Presented by Dr Lauren Eberly
  • NOTIFY-HF: A Randomised Pilot Trial of Patient-Facing HeartLogic Alerts in Heart Failure Patients – Presented by Dr Joseph Assad
  • Automated Notifications to Improve Referral and Treatment of Severe Aortic Stenosis and Mitral Regurgitation: Outcomes from the Randomized ALERT Trial – Presented by Dr Wayne Batchelor

  • A Randomized Controlled Trial of a Novel Just-in-Time Adaptive Mobile Application Intervention to Reduce Sodium Intake and Blood Pressure in Patients with Hypertension – Presented by Dr Michael Dorsch

     

Featured Clinical Research Session V

Monday 30 March 2026, 08:30–09:25 CST

  • The Role of Atrial Pacing Support in Cardiac Resynchronization Therapy: A Non-Inferiority Randomized Trial – Presented by Dr Mauro Biffi
  • Efficacy and Safety of BHB/HRS-1893 in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results from a 12-Week Phase 2 Study – Presented by Dr Lianming Kang
  • Two-Year Outcomes of Transcatheter Tricuspid Valve Replacement for Severe Tricuspid Regurgitation: The TRISCEND II Randomized Trial – Presented by Dr Vinod Thourani

  • Prehospital Heparin Administration in Patients with STEMI Undergoing Primary PCI – Presented by Dr Misa Fister

     

Reference

American College of Cardiology. ACC.26 Scientific Session Program. https://www.acc.org/ACC26 (accessed Friday 23rd January, 2026).

Share: